Physician profile
Benjamin T Warta
NPI 1174573414
$4,731.54
in general payments reported to CMS, 2019-2025
20 companies · $699 in 2025
The $699 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $788 · 2020: $381 · 2021: $589 · 2022: $1,082 · 2023: $745 · 2024: $448 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,892.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,092.27 | 2019-2025 | Precision 1, Precision7, Total30 |
| Coopervision INC. | $1,024.55 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Paragon Crt |
| Bausch & Lomb Americas INC. | $609.89 | 2022-2025 | Infuse, Xiidra, Miebo |
| Johnson & Johnson Vision Care, INC. | $609.60 | 2019-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $252.23 | 2019-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $237.90 | 2019-2020 | |
| Ivantis, INC | $158.63 | 2021 | |
| Glaukos Corporation | $154.38 | 2020 | |
| Notal Vision, INC. | $149.69 | 2021-2022 | |
| Abbvie INC. | $111.03 | 2022-2023 | Alphagan P, Lumigan, Vuity |
| Novartis Pharmaceuticals Corporation | $85.83 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $61.80 | 2025 | Xdemvy |
| Biotissue Holdings INC. | $30.74 | 2020-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $29.56 | 2022 | |
| Oyster Point Pharma, INC. | $26.11 | 2024 | Ryzumvi, Tyrvaya |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $24.80 | 2019 | |
| Mallinckrodt Hospital Products INC. | $21.76 | 2023 | Acthar |
| Eyevance Pharmaceuticals LLC | $21.72 | 2022 | |
| Allergan, INC. | $19.65 | 2022 | |
| Abb Con-Cise Optical Group LLC | $9.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Warta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.